Name : Semafull Composition : Semaglutide Strength : 8mg Manufactured by : NATCO PHARMA LTD Form : Injection Packing : 3ml Uses : Treatment of Type 2 diabetes mellitus
Semafull Injection contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is supplied as a multiple-dose vial containing Semaglutide 8 mg/3 mL (2.68 mg/mL). The vial is designed to deliver a 2 mg dose and is intended for once-weekly subcutaneous use.
